97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

  
9 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2100046446
2021-07-012021-05-15Effect of probiotics supplementation combined with WeChat platform health management on nutritional status, inflammatory factors, and quality of life in patients with mild-to-moderate ulcerative colitisEffect of probiotics supplementation combined with WeChat platform health management on nutritional status, inflammatory factors, and quality of life in patients with mild-to-moderate ulcerative colitis ulcerative colitisexperimental group:Bifidobacterium triple live bacteria combined with WeChat platform for health management intervention;control group:Mesalazine Oral;Affiliated Hospital of Jiangnan UniversityNULLRecruiting1880Bothexperimental group:70;control group:70;N/AChina
2ChiCTR2000032498
2020-09-012020-04-30Human experimental study on the effect of probiotics combined with prebiotics on ulcerative colitis: a randomized double-blind controlled trialHuman experimental study on the effect of probiotics combined with prebiotics on ulcerative colitis Ulcerative colitisExperimental group:Probiotics and prebiotics;placebo group:maltodextrin;Capital Medical UniversityNULLPendingBothExperimental group:15;placebo group:15;China
3NCT04006977
(ClinicalTrials.gov)
October 20191/7/2019Multistrain Probiotics Reduces UC Depression and Anxiety ScoresMultistrain Probiotic Product (De Simone Formulation) Reduces Depression and Anxiety Scores: a Randomized Pilot Study in Patients With Ulcerative ColitisUlcerative ColitisDietary Supplement: a multistrain probiotic product (DSF);Dietary Supplement: PlaceboXijing Hospital of Digestive DiseasesMENDES SANot yet recruiting18 Years65 YearsAll60N/AChina
4ChiCTR1900022243
2019-04-012019-03-31Effect of curcumin combined with probiotics on prevention and treatment in ileal pouchitis after operation of ulcerative colitis.Effect of curcumin combined with probiotics on prevention and treatment in ileal pouchitis after operation of ulcerative colitis. ileal pouchitis after operation of ulcerative colitisExperimental group:Curcumin+Probiotics;Control group:Probiotics;Tianjin Medical University General HospitalNULLRecruitingBothExperimental group:20;Control group:10;China
5NCT04969679
(ClinicalTrials.gov)
March 16, 20187/7/2021Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effect of Mutaflor in Patients With Mild-to-moderate Ulcerative Colitis on 5-ASA Treatment.Ulcerative ColitisDrug: E. coli Nissle 1917 (Mutaflor®);Drug: PlaceboKangbuk Samsung HospitalNULLCompleted19 YearsN/AAll134Phase 4Korea, Republic of
6ChiCTR-IPR-17010306
2017-02-012017-01-01Effects of probiotics on intestinal microecological reconstruction in patients with ulcerative colitisEffects of probiotics on intestinal microecological reconstruction in patients with ulcerative colitis Ulcerative colitisGroup A:Mesalazine combined with placebo; Group B:Methalazine combined with probiotics;Group C:Probiotics combined with placebo;Normal control group:Blank control;Affiliated Hospital of Inner Mongolia Medical UniversityNULLPending18BothGroup A:30; Group B:30;Group C:30;Normal control group:30;China
7NCT01078935
(ClinicalTrials.gov)
December 20121/3/2010The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of InflammationThe Effect of Probiotics on Bowel DiseaseCrohn's Disease;Ulcerative ColitisDietary Supplement: probiotics;Dietary Supplement: placeboThe Baruch Padeh Medical Center, PoriyaMinistry of Health, IsraelNot yet recruiting18 Years80 YearsBoth100Phase 4NULL
8NCT00578799
(ClinicalTrials.gov)
December 200718/12/2007Effects of Probiotics in Patients With Ulcerative ColitisEffects of Probiotics in Patients With Ulcerative Colitis.Ulcerative ColitisDietary Supplement: Kyo-Dophilus;Dietary Supplement: placeboUniversity of California, IrvineWakunaga Pharmaceutical Co., Ltd.Withdrawn18 Years65 YearsAll0Phase 1United States
9NCT00510978
(ClinicalTrials.gov)
January 20022/8/2007Probiotics in GastroIntestinal DisordersOne Year, Randomised, Double Blind, Placebo Controlled Trial of Probiotics, Bifidobacterium Infantis 35624 or Lactobacillus Salivarius UCC118, as Food Supplements for Maintenance of Remission in Crohn's Disease and Ulcerative ColitisUlcerative Colitis;Crohn's DiseaseBiological: Bifidobacterium infantis 35624;Biological: Lactobacillus salivarius UCC118;Biological: PlaceboUniversity College CorkEuropean CommissionActive, not recruitingN/A75 YearsBoth360Phase 2/Phase 3Ireland